IGI receives CIRM CESCG CRP grant to study gene correction for SCD

The IGI has been awarded a CIRM grant to develop next-generation sequencing approaches to track gene correction in bone marrow stem cells for the treatment of sickle cell disease. The CIRM Center of Excellence in Stem Cell Genomics (CESCG) Collaborative Research Program (CRP) supports collaborative research projects by providing California scientists with access to cutting-edge genomics and bioinformatics technologies, and expertise and assistance in experimental design and data analysis. Working with CESCG, the IGI will determine how bone marrow stem cells respond to genetic engineering, characterize on- and off-target gene editing in these challenging cells, and work to move research on a gene editing cure for sickle cell disease closer to the clinic.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

September 8, 2021

Congratulations to Mandy!

Congratulations to Mandy and team for winning the audience vote at the ETH 3Pi Pitch Competition, where ETH Pioneer Fellows pitched their projects to an audience...

September 1, 2021

Lab retreat in Zermatt

Our lab retreat for 2021 was held in Zermatt, in view of the Matterhorn. We spent the first day doing extemporaneous speed talks (3 minutes maximum!) and discussing...

June 17, 2021

Congratulations to Eric and John on the EMBO fellowships!

We are excited to share the news that Eric Aird and John Fielden were both awarded EMBO long-term fellowships, which support excellent postdoctoral researchers...

News Archive

Tweets